Atg7 inhibition is associated with decreased leukemia-initiating cells and prolonged survival of immunodeficient mice with disseminated AML [70, 203, 204], suggesting a therapeutic role for ATG7 inhibition in AML. The gene discussed is ATG7; the disease is leukemia.